These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9751363

  • 1. Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database.
    Grossfeld GD, Stier DM, Flanders SC, Henning JM, Schonfeld W, Warolin K, Carroll PR.
    J Urol; 1998 Oct; 160(4):1398-404. PubMed ID: 9751363
    [Abstract] [Full Text] [Related]

  • 2. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
    Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll PR.
    J Urol; 2000 Apr; 163(4):1171-7; quiz 1295. PubMed ID: 10737489
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [Abstract] [Full Text] [Related]

  • 5. Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.
    Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carroll PR.
    J Urol; 2004 Jan; 171(1):215-9. PubMed ID: 14665879
    [Abstract] [Full Text] [Related]

  • 6. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA.
    Cancer; 2002 Dec 01; 95(11):2302-7. PubMed ID: 12436435
    [Abstract] [Full Text] [Related]

  • 7. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR, CaPSURE Investigators.
    J Urol; 2007 Aug 01; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [Abstract] [Full Text] [Related]

  • 8. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 9. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Cancer; 2006 Apr 15; 106(8):1708-14. PubMed ID: 16544313
    [Abstract] [Full Text] [Related]

  • 10. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H, Lau W, Bergstralh E, Blute ML.
    J Urol; 2001 Dec 15; 166(6):2208-15. PubMed ID: 11696737
    [Abstract] [Full Text] [Related]

  • 11. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ.
    J Urol; 2003 Nov 15; 170(5):1860-3. PubMed ID: 14532793
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone.
    Mian BM, Troncoso P, Okihara K, Bhadkamkar V, Johnston D, Reyes AO, Babaian RJ.
    J Urol; 2002 Apr 15; 167(4):1675-80. PubMed ID: 11912386
    [Abstract] [Full Text] [Related]

  • 14. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
    Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS.
    J Urol; 2008 Aug 15; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
    [Abstract] [Full Text] [Related]

  • 15. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
    D'Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ.
    J Urol; 2006 Dec 15; 176(6 Pt 2):S11-5. PubMed ID: 17084157
    [Abstract] [Full Text] [Related]

  • 16. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA.
    Urology; 2004 Mar 15; 63(3):528-31. PubMed ID: 15028451
    [Abstract] [Full Text] [Related]

  • 17. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
    Moul JW, Connelly RR, Lubeck DP, Bauer JJ, Sun L, Flanders SC, Grossfeld GD, Carroll PR.
    J Urol; 2001 Oct 15; 166(4):1322-7. PubMed ID: 11547066
    [Abstract] [Full Text] [Related]

  • 18. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
    Han M, Pound CR, Potter SR, Partin AW, Epstein JI, Walsh PC.
    J Urol; 2001 Mar 15; 165(3):864-6. PubMed ID: 11176487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.